Capstone Asset Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
Capstone Asset Management's AGN Position: Q2 2017 in Review
Capstone Asset Management reduced its Allergan plc (AGN) stake by 9% in Q2 2017, selling an estimated $364K and leaving 15,744 shares worth $3.83M. The position accounts for 0.11% of the portfolio, ranked #226.
Capstone Asset Management first reported a position in AGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $4.61M in Q1 2015. 1,115 funds tracked by Wall St. Rank hold AGN as of Q2 2017.
- Capstone Asset Management held 15,744 shares of Allergan plc worth $3.83M as of Q2 2017.
- Capstone Asset Management sold 1,550 Allergan plc shares in Q2 2017, an estimated $364K.
- Allergan plc made up 0.11% of Capstone Asset Management's portfolio in Q2 2017, its #226 holding.
- Capstone Asset Management first reported a position in Allergan plc in Q2 2013 and has held it in 17 quarters since.
- Capstone Asset Management's Allergan plc position peaked at $4.61M in Q1 2015.
- 1,115 funds tracked by Wall St. Rank held Allergan plc as of Q2 2017.
Based on Capstone Asset Management's 13F filing for Q2 2017, filed 10 Jul 2017.